Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;101:1225-1236
doi: 10.1161/CIRCRESAHA.107.163147
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Latronico, M. V.G.
Right arrow Articles by Condorelli, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Latronico, M. V.G.
Right arrow Articles by Condorelli, G.
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Cardiac development
Right arrow Gene therapy
Right arrow Heart failure - basic studies
Right arrow Ion channels/membrane transport
Right arrow Physiological and pathological control of gene expression
Right arrow Smooth muscle proliferation and differentiation
(Circulation Research. 2007;101:1225.)
© 2007 American Heart Association, Inc.


Review

Emerging Role of MicroRNAs in Cardiovascular Biology

Michael V.G. Latronico, Daniele Catalucci, Gianluigi Condorelli

From the Istituto di Ricovero e Cura a Carattere Scientifico "MultiMedica" (M.V.G.L., D.C., G.C.), Scientific and Technology Pole, Milan, Italy; and Division of Cardiology (D.C., G.C.), Department of Medicine, University of California at San Diego, La Jolla, Calif.

Correspondence to Gianluigi Condorelli, MD, PhD, Division of Cardiology, Department of Medicine, University of California, 9500 Gilman Dr, La Jolla, CA 92093-0613. E-mail gcondorelli{at}ucsd.edu

The heart is among the most conserved organs of the body and is susceptible to defects more than any other organ. Heart malformations, in fact, occur in roughly 1% of newborns. Moreover, cardiovascular disease arising during adult life is among the main causes of morbidity and mortality in developed countries. It is not surprising, therefore, that much effort is being channeled into understanding the development, physiology, and pathology of the cardiovascular system. MicroRNAs, a newly discovered class of small ribonucleotide-based regulators of gene expression, are being implicated in an increasing number of biological processes, and the study of their role in cardiovascular biology is just beginning. Here, we briefly overview microRNAs in general and report on the recent findings regarding their importance for the heart and vasculature, in particular. The new insights that are being gained will permit not only a greater understanding of cardiovascular pathologies but also, hopefully, the development of novel therapeutic strategies.


Key Words: microRNA • heart development • hypertrophy • heart failure • arrhythmias • cardiovascular disease




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
T. Thum, D. Catalucci, and J. Bauersachs
MicroRNAs: novel regulators in cardiac development and disease
Cardiovasc Res, September 1, 2008; 79(4): 562 - 570.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Yang, Y. Lu, and Z. Wang
Control of cardiac excitability by microRNAs
Cardiovasc Res, September 1, 2008; 79(4): 571 - 580.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Luo, H. Lin, Z. Pan, J. Xiao, Y. Zhang, Y. Lu, B. Yang, and Z. Wang
Down-regulation of miR-1/miR-133 Contributes to Re-expression of Pacemaker Channel Genes HCN2 and HCN4 in Hypertrophic Heart
J. Biol. Chem., July 18, 2008; 283(29): 20045 - 20052.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. Zhang
MicroRNomics: a newly emerging approach for disease biology
Physiol Genomics, April 21, 2008; 33(2): 139 - 147.
[Abstract] [Full Text] [PDF]